Evidence map›Paper›PMID 40936315›Full record

ArticleSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2025

Enhanced Skin Permeation and Pigmentation Reduction Effects of a Novel Tranexamic Acid-Mandelic Acid Ion-Pairing Complex.

Hyungjoon Jeon, Nojin Park, Jong Gu Won, Yong Won Shin, Jiwon Choi, Kyoungin Min, Eunjung Choi, Chang Kyu Kim, Sang-Wook Park, Nam Seo Son

Abstract read
In one paragraph

Article in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Enhanced Skin Permeation and Pigmentation Reduction Effects of a Novel Tranexamic Acid-Mandelic Acid Ion-Pairing Complex.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hyungjoon JeonLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Nojin ParkLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Jong Gu WonLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Yong Won ShinLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Jiwon ChoiLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Kyoungin MinLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Eunjung ChoiLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Chang Kyu KimLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Sang-Wook ParkLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.
Nam Seo SonLG Household & Health Care (LG H&H), LG Science Park, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigated the enhanced skin permeation and pigmentation reduction effects of an ion-pair complex formed between tranexamic acid (TXA) and mandelic acid (MA). The TXA-MA complex demonstrated superior skin permeability and greater inhibition of cytokine expression compared to TXA alone, ultimately proving more effective in reducing skin pigmentation.

methodsAfter spectroscopic analysis of the TXA-MA ion-pairing complex (TXA-MA complex) structure, an in vitro skin permeation study was conducted using a Franz cell system with porcine skin. Additionally, the effect of the TXA-MA complex on UVB (ultraviolet B)-induced expression changes of inflammation-related genes (IL-1α, IL-6, IL-8, COX2) was evaluated using a human epidermal keratinocyte cell lines (HaCaT) cell model. Finally, an in vivo human study was performed to analyze the efficacy of TXA-MA in reducing actual skin pigmentation.

resultsThe formation of the TXA-MA complex was confirmed through zeta-potential measurements,

conclusionThis study successfully formed a TXA-MA complex. Compared to TXA, the TXA-MA complex showed superior effects in skin permeability, inhibition of inflammatory marker expression, and actual skin pigmentation reduction. These results suggest that the TXA-MA complex holds greater potential as an effective cosmetic ingredient for pigmentation improvement than TXA alone.

Indexed as

Mandelic AcidsSkin AbsorptionSkin PigmentationTranexamic AcidAdultAnimalsCytokinesFemaleHaCaT CellsHumansKeratinocytesPermeabilitySkinSwineCytokinesMandelic AcidsTranexamic Acidinflammationion‐pairingmandelic acidskin permeationskin pigmentationtranexamic acid

Identifiers

PMID40936315
PMCPMC12426310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.